CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities
Net loss	$ (4,061,186)	$ (4,044,466)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	38,004	38,444
Amortization of debt discounts	349,548	19,957
Amortization of stock based prepaid consulting		42,500
Vesting of restricted stock units	90,000
Stock option employee compensation expense	1,234,945	1,002,060
Cost of repricing warrants to induce exercise	70,491	17,753
Loss on disposal of assets	9,822
Loss on stock issued for interest	4,205
Common stock issued as settlement		300,000
Reversal of litigation accrual	(941,000)
Payment by insurance company of prior period accrued litigation expense	(200,000)
Changes in assets and liabilities:
Accounts receivable	5,831	69,069
Inventories	(123,213)	(154,137)
Prepaid expenses and other current assets	44,290	28,944
Other assets	(11,255)
Accounts payable	202,978	(127,758)
Accrual for severance agreement	144,286
Accrued expenses	67,001	(83,989)
Net cash used in operating activities	(3,075,253)	(2,891,623)
Cash flows from Investing Activities
Proceeds sale of asset	15,000
Purchases of equipment	(27,973)	(28,949)
Net cash (used in) investing activities	(12,973)	(28,949)
Cash flows from Financing Activities
Proceeds from sale of stock through private placements	1,258,000	566,700
Proceeds from sale of stock under stock purchase agreement	810,003
Proceeds from exercise of warrants	910,000	107,500
Proceeds from exercise of stock options		33,335
Proceeds from related party advances		89,380
Payment on related party notes	(84,219)
Proceeds from convertible notes with third parties	175,000	105,000
Proceeds from convertible notes with related parties	500,000	325,000
Payments on Insurance Finance Contract	(34,752)	(33,013)
Net cash provided by financing activities	3,534,032	1,193,902
Net increase in cash and cash equivalents	445,806	(1,726,670)
Cash and cash equivalents - beginning	84,194	1,956,976
Cash and cash equivalents - ending	530,000	230,306
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	836	1,601
Cash paid for income taxes
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Financing of prepaid insurance contracts	47,471	43,931
Beneficial conversion feature of convertible notes	195,770	84,562
Conversion of notes for common stock	459,067
Note issued for accrued interest		74,874
Common stock issued for interest	$ 73,579